A simple, rapid, precise, accurate and cost effective stability-indicating reversed phase (RP) HPLC related substance method-1 was validated for Hydralazine Hydrochloride (HYD HCl) in Active pharmaceutical ingredient. All the analytical parameters were determined as per ICH Q2B guidelines. Good chromatographic separation was achieved with Inertsil ODS 3V column (4.6 mm x 250 mm, 5 μm particle size) at a wavelength of 230 nm using phosphate buffer pH 2.5 and acetonitrile as mobile phase A and Methanol as mobile phase B with gradient programming with a flow rate of 1.0 ml/ min. The Resolution between Hydralazine peak and impurity-A should not be less than 3.0. From the statistical treatment of the linearity data of Hydralazine HCl, it is clear that the response of Hydralazine HCl is linear between 50 % to 150 % level. The correlation coefficient is greater than 0.998. The developed method showed good linearity, Accuracy, reproducibility, precision and robustness and can be suitably applied for the routine quality control analysis in the estimation of commercial formulations. 
INTRODUCTION
Hydralazine HCl is chemically 1-hydrazinylphthalazine. With molecular formula-C8H8N4 and 160.17 mg molecular weight. It is freely soluble in water and sparingly soluble in methaline chloride. Hydralazine is a direct-acting smooth muscle relaxant. It is used as an antihypertensive agent in cases like preeclampsia (a condition in pregnancy characterized by high blood pressure). Hydralazine HCl acts by increasing cyclic guanosine mono-phosphate (cGMP) levels which causes an increase in the activity of protein kinase G (PKG). This results in blood vessel relaxation and causes dilation of arteries and arterioles [1] [2] [3] .
Figure 1: Chemical structure of Hydralazine HCl

Objective of Study
Literature survey revealed that Methods for the determinations of Hydralazine HCl include HPLC, Gas chromatography, simultaneous spectrophotometric determination and other methods. Literature survey reveals that different assay methods like spectrophotometry, spectrofluorometry, oxidimetry, and HPLC are available for the validation of Hydralazine hydrochloride in drug substances, But none of these methods are found suitable for routine quality control studies due to the following reasons like poor sensitivity, longer run time, using costly solvent, suitable at higher concentration only, extraction procedure involved in sample preparation [4] [5] [6] . Based on this, it was felt necessary to develop a validated simple, selective and sensitive HPLC method for the determination of Hydralazine hydrochloride in drug substances. The proposed method has been demonstrated superior to the existing procedures due to its sensitivity, speed, accuracy and it is suitable for routine quality control analysis. This proposed method can be successfully employed for quality control during = Area of any other individual impurity X wt of Hydralazine.std (mg) X 2 X 5 X 50 X P2 Avg.peak area of Hydralazine in Standard X 100 X 50 X50 X Sample Weight(mg)
Where,
P1=Potency of Impurity standard
P2=Potency of Hydralazine HCl standard %Total impurities = %Impurity A+% of Impurity B+% Impurity C+%Impurity D +% Total other impurities 
RESULTS AND DISCUSSION
Specificity: Blank (diluent), system suitability solution, diluted standard solution, all known impurity solutions individually, sample solution and sample solution spiked with all known impurities at specification level were prepared and injected into the HPLC equipped with a photodiode array detector and analysed. Peak purity passed for Hydralazine and its related impurities in control sample and spiked sample. Data is reported in Table 3 and Figure 2 , 3,4 and 5. From the above data, it is clear that, Hydralazine, Impurity-A, Impurity-B, Impurity-C and Impurity-Dare well separated from each other and Hydralazine peak. There is no interference of Blank at the retention time of all known impurities and unknown Impurities. Peak Purity is passes for Hydralazine peak and all known impurities. Based on the above data method is Specific. 
LOD Confirmation and LOQ Precision:
The Resolution between Hydralazine peak and Impurity A peak is 23.4 (NLT 3.0). %RSD of six replicates of standard solution is Complies (NMT 5.0%). System suitability parameter Complies. From the below given results, it is concluded that method is precise at LOQ Level. All individual known impurities were detectable at LOD level concentration. Accuracy: Sample of Hydralazine hydrochloride drug substances, were spiked with Impurities A, B, C and D at four different levels: LOQ, 50%, 100%, and 150% of specification limits (in triplicate (in total twelve determinations) and analysed. The Mean Recovery for known impurities is within limits. Therefore, the HPLC Method for the determination of related substances method-1 of Hydralazine hydrochloride in Hydralazine hydrochloride drug substances is accurate. Accuracy reported in Table 10 . System Precision: Six replicate injections of the standard solution were made & injected. RSD should not be more than 5.0% and The Resolution between Hydralazine peak and Impurity A peak is 22.1 (NLT 3.0). The RSD of system precision is 2.43 %.
Method Precision: Six Sample solutions of hydralazine hydrochloride spiked with Known impurities was prepared and injected into the HPLC, along with standard solution. RSD should not be more than 10.0%. RSD is less than 10.0%. Therefore, the HPLC Method for the determination of related substances of hydralazine hydrochloride (Method-1) is precise.
Ruggedness (Intermediate Precision): Six Sample solutions of the same lot of hydralazine hydrochloride, spiked with known impurities was made by a different analyst and analysed using different column on a different day and injected into a different HPLC, along with Standard solution. Overall RSD is less than 10.0%. Therefore, the HPLC Method for the determination of related substances of hydralazine hydrochloride (Method-1) is rugged. Based on the above data it is clear the method is Precise &Rugged. Precision and ruggedness data summarized in Table 11 . 
